NewCo Model: China’s Innovative Drug Companies’ New Transaction Mode in Capital Winter
NewCo is a new transaction model developed by Chinese innovative drug companies in response to...
Verdiva Bio
Verdiva Bio Launches with USD 411 Million Series A Financing for Biopharma Development
UK-based Verdiva Bio Limited has announced its launch as a clinical-stage biopharma company, backed by...
SciWind Bio and Verdiva Bio Partner on Global Development of Obesity Therapies
On January 10, SciWind Bio announced a global development and commercialization license and collaboration agreement...